Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot

Targeting the activation of immune checkpoints is recognized as an effective strategy for triggering anti-tumour immune responses in cancer cells. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) were identified as potential crucial targets for cancer t...

Full description

Bibliographic Details
Main Authors: Ronny Sham, Nur Fatihah, Abdul Hamid Hasani, Narimah, Idorus, Mohd Yusri, Abdul Karim, Muhammad Khalis, Syed Ahmad Fuad, Syed Baharom, Hasbullah, Harissa Husainy, Ibahim, Mohammad Johari
Format: Article
Published: Penerbit UTM Press 2023
_version_ 1811137955933192192
author Ronny Sham, Nur Fatihah
Abdul Hamid Hasani, Narimah
Idorus, Mohd Yusri
Abdul Karim, Muhammad Khalis
Syed Ahmad Fuad, Syed Baharom
Hasbullah, Harissa Husainy
Ibahim, Mohammad Johari
author_facet Ronny Sham, Nur Fatihah
Abdul Hamid Hasani, Narimah
Idorus, Mohd Yusri
Abdul Karim, Muhammad Khalis
Syed Ahmad Fuad, Syed Baharom
Hasbullah, Harissa Husainy
Ibahim, Mohammad Johari
author_sort Ronny Sham, Nur Fatihah
collection UPM
description Targeting the activation of immune checkpoints is recognized as an effective strategy for triggering anti-tumour immune responses in cancer cells. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) were identified as potential crucial targets for cancer treatment. Overexpression of CTLA-4 and PD-1 proteins in primary tumour and human cell lines is well documented. In contrary, lack of data was available using animal cell lines. The presence study aims to optimize the expression of CTLA-4 and PD-1 proteins in EMT6 mouse mammary cancer cells using Western blot, and provide basic understanding of their association with breast cancer cell progression. Proteins extracted from EMT6 parental cells were adjusted to 30ng for gel electrophoresis. Afterwards, the protein was transferred to a nitrocellulose membrane for blotting. The membrane was then subjected to chemiluminescent for band detection. Results obtained using beta-actin as a housekeeping gene show that both CTLA-4 (32 kDa) and PD-1 (34 kDa) proteins were expressed by using a 1:1000 dilution for each antibody from the lysate of EMT6 mouse mammary cancer cells. The relative expression of PD-1 (4.0 ± 0.26) is higher compared to CTLA-4 (1.2 ± 1.8).  As a conclusion, both CTLA-4 and PD-1 proteins were indeed expressed in EMT6 mouse mammary cancer cells and this outcome provide the platform for extensive in vivo research on the link of both proteins with breast cancer using animal model.
first_indexed 2024-09-25T03:42:32Z
format Article
id upm.eprints-110114
institution Universiti Putra Malaysia
last_indexed 2024-09-25T03:42:32Z
publishDate 2023
publisher Penerbit UTM Press
record_format dspace
spelling upm.eprints-1101142024-09-05T07:16:19Z http://psasir.upm.edu.my/id/eprint/110114/ Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot Ronny Sham, Nur Fatihah Abdul Hamid Hasani, Narimah Idorus, Mohd Yusri Abdul Karim, Muhammad Khalis Syed Ahmad Fuad, Syed Baharom Hasbullah, Harissa Husainy Ibahim, Mohammad Johari Targeting the activation of immune checkpoints is recognized as an effective strategy for triggering anti-tumour immune responses in cancer cells. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) were identified as potential crucial targets for cancer treatment. Overexpression of CTLA-4 and PD-1 proteins in primary tumour and human cell lines is well documented. In contrary, lack of data was available using animal cell lines. The presence study aims to optimize the expression of CTLA-4 and PD-1 proteins in EMT6 mouse mammary cancer cells using Western blot, and provide basic understanding of their association with breast cancer cell progression. Proteins extracted from EMT6 parental cells were adjusted to 30ng for gel electrophoresis. Afterwards, the protein was transferred to a nitrocellulose membrane for blotting. The membrane was then subjected to chemiluminescent for band detection. Results obtained using beta-actin as a housekeeping gene show that both CTLA-4 (32 kDa) and PD-1 (34 kDa) proteins were expressed by using a 1:1000 dilution for each antibody from the lysate of EMT6 mouse mammary cancer cells. The relative expression of PD-1 (4.0 ± 0.26) is higher compared to CTLA-4 (1.2 ± 1.8).  As a conclusion, both CTLA-4 and PD-1 proteins were indeed expressed in EMT6 mouse mammary cancer cells and this outcome provide the platform for extensive in vivo research on the link of both proteins with breast cancer using animal model. Penerbit UTM Press 2023 Article PeerReviewed Ronny Sham, Nur Fatihah and Abdul Hamid Hasani, Narimah and Idorus, Mohd Yusri and Abdul Karim, Muhammad Khalis and Syed Ahmad Fuad, Syed Baharom and Hasbullah, Harissa Husainy and Ibahim, Mohammad Johari (2023) Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot. Malaysian Journal of Fundamental and Applied Sciences, 19. pp. 194-201. ISSN 2289-5981; ESSN: 2289-599X https://mjfas.utm.my/index.php/mjfas/article/view/2700 10.11113/mjfas.v19n2.2700
spellingShingle Ronny Sham, Nur Fatihah
Abdul Hamid Hasani, Narimah
Idorus, Mohd Yusri
Abdul Karim, Muhammad Khalis
Syed Ahmad Fuad, Syed Baharom
Hasbullah, Harissa Husainy
Ibahim, Mohammad Johari
Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot
title Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot
title_full Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot
title_fullStr Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot
title_full_unstemmed Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot
title_short Optimization of CTLA-4 and pd-1 proteins in EMT6 mouse mammary cancer cells by Western blot
title_sort optimization of ctla 4 and pd 1 proteins in emt6 mouse mammary cancer cells by western blot
work_keys_str_mv AT ronnyshamnurfatihah optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot
AT abdulhamidhasaninarimah optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot
AT idorusmohdyusri optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot
AT abdulkarimmuhammadkhalis optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot
AT syedahmadfuadsyedbaharom optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot
AT hasbullahharissahusainy optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot
AT ibahimmohammadjohari optimizationofctla4andpd1proteinsinemt6mousemammarycancercellsbywesternblot